FDA: Johnson & Johnson's one-shot vaccine prevents COVID; final decision soon
A final decision could come as early as Friday.
Johnson & Johnson’s single-dose vaccine protects against COVID-19, federal regulators said Wednesday, paving the way for a final approval as early as this week.
The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot – which could help speed vaccinations by requiring just one dose instead of two – is safe to use, according to the Associated Press.
That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S.
On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot, the wire service also reports.
News, Not Noise
- Trump's post-D.C. plan takes shape with rollout of America First funding, policy, messaging arms
- Oregon considers making mask mandate permanent, infuriating residents
- Arizona Senate on the verge of beginning major audit of Maricopa County ballots
- Hunter Biden's book 'Beautiful Things' sells less than 11k copies in first week, despite PR rush
- As corporations bow to left's agenda, conservatives eye mass boycotts of woke brands